Neurocrine Biosciences, Inc.
NASDAQ:NBIX 3:59:51 PM EDT
| Market Cap (Intraday) | 9.06B |
| Current PE | 24.84 |
| Forward PE | 43.9 |
| 2yr Forward PE | 24.66 |
| 10-Day MA | $95.48 |
| 50-Day MA | $93.96 |
| 200-Day MA | $98.19 |
Neurocrine Biosciences, Inc. Stock, NASDAQ:NBIX
12780 El Camino Real, San Diego, California 92130
United States of America
Phone: +1.858.617.7600
Number of Employees: 845
Description
Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company. It discovers, develops and intends to commercialize drugs for the treatment of neurological and endocrine related diseases and disorders. The firm's product includes INGREZZA. The company was founded by Kevin C. Gorman and Wylie W. Vale in January 1992 and is headquartered in San Diego, CA.